|
175. Yang, J.; Zhu, B.; Zhang, J.; Liang, S. H.; Shen, S. and Ran, C. “Half-curcumin-based chemiluminescence probes and their applications in detecting quasi-stable oxidized proteins”, Angewandte Chemie International Edition, 2024, ASAP. Link: https://doi.org/10.1002/anie.202409896
|
|
174. Li, Y.; Dahl, K.; Johnström, P.; Varnäs, K.; Farde, L.; Halldin, C.; Medd, A.; Maier, D.; Powell, M.; Chen, J.; Van, R.; Patel, J.; Chaudhary, A.; Gao, Y.; Song, Z.; Haider, A.; Shao, Y.; Elmore, C.; Liang, S. H. & Schou, M. “Radiosynthesis and Evaluation of 11C-labeled isoindolone-based positive allosteric modulators for PET imaging of Metabotropic Glutamate Receptor 2”, ACS Pharmacology & Translational Science, 2024, ASAP. Link: https://doi.org/10.1021/acsptsci.4c00261.
|
|
173. Hu, J.; Li, Y.; Dong, C.; Wei, H.; Liao, K.; Wei, J.; Zhao, C.; Chaudhary, A.; Chen, J.; Xu, H.; Zhong, K.; Liang, S. H.; Wang, L. & Ye, W. “Discovery and evaluation of a novel 18F-labled vasopressin 1a receptor PET ligand with peripheral binding specificity”, Acta Pharm Sin B. 2024, 2211-3835. Link: https://doi.org/10.1016/j.apsb.2024.05.033
|
|
172. Zhang, W.; Li, Y. and Liang, S. H. “Radiodifluoromethylation of well-functionalized molecules“, Am J Nucl Med Mol Imaging, 2024, Accepted.
|
|
171. Pees, A.; Tong, J.; Birudaraju, S.; Munot, Y. S.; Liang, S. H.; Saturnino Guarino, D.; Mach, R.; Mathis, C. A.; Vasdev, N. “Development of Pyridothiophene Compounds for PET Imaging of α-Synuclein”, Chemistry – A European Journal, 2024, e202303921.
leave blank |
|
170. Jeppesen, T. E.; Shao, T.; Chen, J.; Patel, J. S.; Zhou, X.; Kjaer, A. and Liang, S. H. “Poly (ADP-ribose) Polymerase (PARP)-targeted PET Imaging in Non-oncology Application: A Pilot Study in Preclinical Models of Nonalcoholic Steatohepatitis”, Am J Nucl Med Mol Imaging, 2024, Accepted.
|
|
169. Liu, J.; Rong, J.; Wood, D. P.; Wang, Y.; Liang, S. H. and Lin, S. “Co-Catalyzed Hydrofluorination of Alkenes: Photocatalytic Method Development and Electroanalytical Mechanistic Investigation”, Journal of the American Chemical Society, 2024, accepted.
|
|
168. Chen, J.; Li, Y.; Yu, Q.; Patel, S. J.; Zhou, X.; Zhang, K.; Rong, J.; Zhao, C.; Chaudhary, F. A.; Zhang, W.; Bi, C.; Song, Z.; April T. Davenport, A. T.; Daunais, J. B.; Haider, A.; Collier, L.; Yuan, H.; and Liang, S. H. “Preclinical Evaluation of Azabenzimidazole-Based PET Radioligands for γ-8 Dependent Transmembrane AMPA Receptor Regulatory Protein Imaging”, ChemBioChem, 2024, accepted.
|
|
167. Ahmed, H.; Wang, Y.; Griffiths, W. J.; Levey, A. I.; Pikuleva, I.; Liang, S. H. and Haider, A. “Brain Cholesterol and Alzheimer’s Disease–Challenges and Opportunities in Probe and Drug Development”, Brain, 2024, accepted. link: https://pubmed.ncbi.nlm.nih.gov/38301270/
|
|
166. Chen, Z.; Chen, J.; Wakana, M.; Yi, Y.; Rong, J.; Li, Y.; Leon, C. E.; Shao, T.; Song, Z.; Yamasaki, T.; Zhang, Y.; Josephson, L.; Van, R. S.; Shao, Y.; Zhang, M-R. and Liang, S. H. “Preclinical evaluation of novel positron emission tomography (PET) probes for imaging leucine-rich repeat kinase 2 (LRRK2)”, Journal of Medicinal Chemistry, 2024, accepted.
 |
